NxStage Medical Inc (NXTM)

27.77
NASDAQ : Health Care
Prev Close 27.75
Day Low/High 27.72 / 27.80
52 Wk Low/High 20.45 / 30.80
Avg Volume 1.53M
Exchange NASDAQ
Shares Outstanding 66.01M
Market Cap 1.83B
EPS -0.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

NxStage Medical Stock Sees Short Interest Decrease By 26.3%

NxStage Medical Stock Sees Short Interest Decrease By 26.3%

The most recent short interest data has been released for the 08/15/2017 settlement date, which shows a 796,859 share decrease in total short interest for NxStage Medical Inc , to 2,234,165, a decrease of 26.29% since 07/31/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Interesting NXTM Put Options For October 20th

Investors in NxStage Medical Inc saw new options begin trading this week, for the October 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NXTM options chain for the new October 20th contracts and identified the following put contract of particular interest.

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors Of An Investigation Concerning Whether The Sale Of NxStage Medical, Inc. To Fresenius Medical Care For $30 Per Share Is Fair To Shareholders

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors Of An Investigation Concerning Whether The Sale Of NxStage Medical, Inc. To Fresenius Medical Care For $30 Per Share Is Fair To Shareholders

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased NxStage Medical, Inc.

NXSTAGE MEDICAL, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes The Acquisition By Fresenius Medical Care May Be Unfair To Shareholders

NXSTAGE MEDICAL, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe Believes The Acquisition By Fresenius Medical Care May Be Unfair To Shareholders

Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of NxStage Medical, Inc.

Dow Scores Ninth Straight Record Close With Tiny Gains, S&P 500 at All-Time High

Dow Scores Ninth Straight Record Close With Tiny Gains, S&P 500 at All-Time High

DJIA, S&P 500 and Nasdaq all rise slightly on the session.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of Commencement Of An Investigation Concerning Whether The Sale Of NxStage Medical, Inc. To Fresenius Medical Care For $30 Per Share Is Fair To Shareholders

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of Commencement Of An Investigation Concerning Whether The Sale Of NxStage Medical, Inc. To Fresenius Medical Care For $30 Per Share Is Fair To Shareholders

The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased NxStage Medical, Inc.

Dow Is Back on Track to Close at a Record High as Consumer Staples Lead

Dow Is Back on Track to Close at a Record High as Consumer Staples Lead

The Dow has closed with a record for eight straight days. It's going for its ninth.

You Can't Force Action in an Environment Like This

You Can't Force Action in an Environment Like This

There's no advantage in trying to predict the next move right now.

Energy Losses Put Dow's Record-Breaking Streak in Jeopardy

Energy Losses Put Dow's Record-Breaking Streak in Jeopardy

The Dow could close with its ninth day of records.

Stock Futures Rise as Dow Shoots for Its Ninth Straight Day of Records

Stock Futures Rise as Dow Shoots for Its Ninth Straight Day of Records

Stock futures are higher.

NxStage Medical Acquired by Fresenius for $2 Billion

NxStage Medical Acquired by Fresenius for $2 Billion

NxStage had $366 million in revenue last year.

Fresenius Medical Care To Acquire NxStage Medical, Inc. To Strengthen Its Vertically Integrated Dialysis Business

Fresenius Medical Care To Acquire NxStage Medical, Inc. To Strengthen Its Vertically Integrated Dialysis Business

Fresenius Medical Care, the world's largest provider of dialysis products and services, has signed an agreement to acquire NxStage Medical, Inc.

First Week of August 18th Options Trading For NxStage Medical (NXTM)

Investors in NxStage Medical Inc saw new options become available this week, for the August 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NXTM options chain for the new August 18th contracts and identified one put and one call contract of particular interest.

Notable Two Hundred Day Moving Average Cross - NXTM

In trading on Tuesday, shares of NxStage Medical Inc crossed below their 200 day moving average of $25.67, changing hands as low as $20.45 per share. NxStage Medical Inc shares are currently trading off about 15.6% on the day.

TheStreet Quant Rating: C (Hold)